Published in J Antimicrob Chemother on March 01, 1980
Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study. Antimicrob Agents Chemother (2001) 2.03
Comparison of amphotericin B and N-D-ornithyl amphotericin B methyl ester in experimental cryptococcal meningitis and Candida albicans endocarditis with pyelonephritis. Antimicrob Agents Chemother (1985) 1.78
Tissue concentrations and bioactivity of amphotericin B in cancer patients treated with amphotericin B-deoxycholate. Antimicrob Agents Chemother (1989) 1.48
Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients. Antimicrob Agents Chemother (1998) 1.37
Induction of amphotericin B-specific antibodies for use in immunoassays. Antimicrob Agents Chemother (1984) 0.85
Pharmacokinetics and buccal mucosal concentrations of a 15 milligram per kilogram of body weight total dose of liposomal amphotericin B administered as a single dose (15 mg/kg), weekly dose (7.5 mg/kg), or daily dose (1 mg/kg) in peripheral stem cell transplant patients. Antimicrob Agents Chemother (2009) 0.84
Comparative neurotoxicities of amphotericin B and its mono-methyl ester derivative in rats. Antimicrob Agents Chemother (1993) 0.80
Measurement of the concentration of amphotericin B in brain tissue of scrapie-infected hamsters with a simple and sensitive method. Antimicrob Agents Chemother (1991) 0.78
Amphotericin B severely affects expression and activity of the endothelial constitutive nitric oxide synthase involving altered mRNA stability. Br J Pharmacol (2000) 0.76
Therapy of fungal infections. Bull N Y Acad Med (1982) 0.75
Fungal brain abscess caused by "Black Mold" (Cladophialophora bantiana) - A case report of successful treatment with an emphasis on how fungal brain abscess may be different from bacterial brain abscess. Surg Neurol Int (2017) 0.75
Metachromatic agar-diffusion methods for detecting staphylococcal nuclease activity. Appl Microbiol (1971) 10.60
Obfuscation of the activity of antifungal antimicrobics by culture media. J Infect Dis (1972) 7.47
Nuclease production and lysostaphin susceptibility of Staphylococcus aureus and other catalase-positive cocci. Appl Microbiol (1971) 3.40
Gentamicin therapy in renal failure: a nomogram for dosage. Ann Intern Med (1972) 2.43
Effect of culture media on the antifungal activity of miconazole and amphotericin B methyl ester. J Infect Dis (1976) 2.31
Diagnostic usefulness and safety of transtracheal aspiration. N Engl J Med (1967) 2.23
Early childhood television viewing and adolescent behavior: the recontact study. Monogr Soc Res Child Dev (2001) 2.12
Susceptibility of three groups of Staphylococcus aureus to newer antimicrobial agents. Antimicrob Agents Chemother (1977) 2.09
An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbits. Science (1998) 1.93
Problems in the diagnosis and treatment of systemic candidiasis. J Infect Dis (1972) 1.83
Candicidin and other polyenic antifungal antibiotics. Bull World Health Organ (1965) 1.82
Miconazole therapy for coccidioidomycosis. JAMA (1974) 1.81
Polyene macrolide derivatives. I. N-acylation and esterification reactions with amphotericin B. J Antibiot (Tokyo) (1972) 1.77
Penetration of antimicrobial agents into bronchial secretions. Am J Med (1975) 1.74
A radioactive antigen-binding assay for the measurement of antibody to Haemophilus influenzae type b capsular polysaccharide. J Immunol Methods (1981) 1.65
Itraconazole treatment of phaeohyphomycosis. J Am Acad Dermatol (1990) 1.57
Prediction of antimeningococcic chemoprophylactic efficacy. J Infect Dis (1971) 1.55
Polyene macrolide derivatives. II. Physical-chemical properties of polyene macrolide esters and their water soluble salts. J Antibiot (Tokyo) (1972) 1.52
Comparison of amphotericin B and amphotericin B methyl ester: efficacy in murine coccidioidomycosis and toxicity. J Infect Dis (1976) 1.52
Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole. J Infect Dis (1975) 1.50
Anti-viral activity of amphotericin B methyl ester: inhibition of HTLV-III replication in cell culture. Biochem Pharmacol (1986) 1.48
Polyene macrolide derivatives. 3. Biological properties of polyene macrolide ester salts. J Antibiot (Tokyo) (1972) 1.47
Effect of buffers on testing of Candida species susceptibility to flucytosine. J Clin Microbiol (1987) 1.44
The effect of polyene macrolides on the prostate gland and canine prostatic hyperplasia. Proc Natl Acad Sci U S A (1968) 1.43
Systemic zygomycosis caused by Apophysomyces elegans. J Med Vet Mycol (1986) 1.42
The relations of early television viewing to school readiness and vocabulary of children from low-income families: the early window project. Child Dev (2001) 1.39
Chemotherapy of systemic fungal diseases. Annu Rev Pharmacol Toxicol (1978) 1.39
Development of resistance to 5-fluorocytosine in Candida parapsilosis during therapy. J Infect Dis (1974) 1.38
Experimental and clinical aspects of resistance determinants. Mode of resistance against beta-lactam antibiotics in staphylococci. Ann N Y Acad Sci (1971) 1.36
Gentamicin versus staphylococcus aureus. J Infect Dis (1969) 1.36
Disk agar diffusion susceptibility testing of yeasts. Antimicrob Agents Chemother (1978) 1.35
Comparative chemotherapeutic activity of amphotericin B and amphotericine B methy ester. Antimicrob Agents Chemother (1975) 1.35
Thermonuclease seroinhibition test for distinguishing Staphylococcus aureus from other coagulase-positive staphylococci. J Clin Microbiol (1979) 1.32
Synthetic medium for susceptibility testing. Antimicrob Agents Chemother (Bethesda) (1970) 1.31
Influence of culture medium on susceptibility testing with BAY n 7133 and ketoconazole. J Clin Microbiol (1986) 1.30
An unusual outbreak of windborne coccidioidomycosis. N Engl J Med (1979) 1.27
Bacteriology of the lower respiratory tract as determined by fiber-optic bronchoscopy and transtracheal aspiration. J Infect Dis (1976) 1.23
Metachromatic agar-diffusion microslide technique for detecting staphylococcal nuclease in foods. Appl Microbiol (1972) 1.20
Nocardial brain abscess cured with cycloserine and sulfonamides. Am J Med Sci (1968) 1.20
Occurrence of protein A in Staphylococcus aureus and closely related Staphylococcus species. J Clin Microbiol (1979) 1.18
Effect of tetracycline, polymyxin B, and rifampin on phagocytosis. Clin Pharmacol Ther (1970) 1.17
Stability of four antifungal antimicrobics in vitro. J Infect Dis (1978) 1.17
Comparative pharmacology of amphotericin B and amphotericin B methyl ester in the non-human primate, Macacca mulatta. Antimicrob Agents Chemother (1977) 1.15
alpha-Phosphonosulfonic acids: potent and selective inhibitors of squalene synthase. J Med Chem (1996) 1.15
Social interactions and play patterns of parents and toddlers with feminine, masculine, and neutral toys. Child Dev (1989) 1.13
Studies on candicidin biogenesis. J Antibiot (Tokyo) (1972) 1.13
Separation of polyene antifungal antibiotics by high-speed liquid chromatography. J Chromatogr (1974) 1.11
Treatment of open fractures: a prospective study. J Trauma (1983) 1.10
Convenient assay for staphylococcal nuclease by the metachromatic well-agar-diffusion technique. Appl Microbiol (1972) 1.10
Polyene macrolide antibiotic amphotericin B. Crystal structure of the N-iodoacetyl derivative. J Am Chem Soc (1971) 1.10
Nafcillin concentration in cerebrospinal fluid during treatment of staphylococcal infections. Ann Intern Med (1977) 1.08
Cloning and characterization of a 3-N-aminoglycoside acetyltransferase gene, aac(3)-Ib, from Pseudomonas aeruginosa. Antimicrob Agents Chemother (1995) 1.07
In vitro antiherpetic activity of water-soluble amphotericin B methyl ester. Arch Virol (1975) 1.06
Susceptibility of "methicillin"-resistant Staphylococcus aureus to 12 antimicrobial agents. Antimicrob Agents Chemother (Bethesda) (1969) 1.05
Effect of nitrogen dioxide on pulmonary bacterial defense mechanisms. Arch Environ Health (1973) 1.05
Prostatic cholesterol metabolism: regulation and alteration. Prog Clin Biol Res (1981) 1.04
Infective endocarditis caused by Streptococcus bovis resistant to the lethal effect of penicillin G. Arch Intern Med (1978) 1.03
Tolerance of staphylococcal thermonuclease to stress. Appl Microbiol (1972) 1.03
The HTLV-III envelope protein contains a hexapeptide homologous to a region of interleukin-2 that binds to the interleukin-2 receptor. Biochem Biophys Res Commun (1986) 1.02
Acquired and native resistance of Staphylococcus aureus to cephalexin and other beta-lactam antibiotics. Appl Microbiol (1970) 1.01
Inhibition of HIV replication by liposomal encapsulated amphotericin B. Antiviral Res (1989) 1.01
Induction of resistance in Staphylococcus aureus and Klebsiella pneumoniae by exposure to cephalothin and cefoxitin. J Infect Dis (1976) 1.00
The separation and differentiation of the gentamicin complex. J Chromatogr (1967) 0.99
Comparative acute toxicity of four drugs. A study of neomycin, gentamicin, kanamycin, and dihydrostreptomycin. Arch Intern Med (1967) 0.99
Dimeric half-molecules of human fibrinogen are joined through disulfide bonds in an antiparallel orientation. Biochemistry (1983) 0.98
Successful treatment of gram-negative bacillary meningitis with moxalactam. Ann Intern Med (1981) 0.98
The polymyxins. Med Clin North Am (1970) 0.97
Stability studies with amphotericin B and amphotericin B methyl ester. J Antibiot (Tokyo) (1975) 0.97
1,1-Bisphosphonate squalene synthase inhibitors: interplay between the isoprenoid subunit and the diphosphate surrogate. J Med Chem (1995) 0.97
Rapid oral desensitization to trimethoprim-sulfamethoxazole in infants and children. Pediatr Infect Dis J (1996) 0.96
Coconut and Salmonella infection. Appl Microbiol (1967) 0.96
A survey of academic anesthesiology. Submitted by ASA Subcommittee (Task Force) on Academic Anesthesia Manpower. Anesthesiology (1977) 0.96
Polyene macrolide antibiotic cytotoxicity and membrane permeability alterations. I. Comparative effects of four classes of polyene macrolides on mammalian cells. J Cell Physiol (1978) 0.95
Occupational portrayals on television: children's role schemata, career aspirations, and perceptions of reality. Child Dev (1995) 0.95
Grouping of gram-negative bacteria and susceptibility to antimicrobial agents. Antimicrob Agents Chemother (Bethesda) (1965) 0.94
In vitro activities of two new antifungal azoles. Antimicrob Agents Chemother (1984) 0.94
Adverse influence of ozone on pulmonary bactericidal activity of murine lung. Nature (1971) 0.94
Postoperative infection of an aortic prosthesis with Achromobacter xylosoxidans. West J Med (1982) 0.94
Hepatotoxicity and transaminase measurement during isoniazid chemoprophylaxis in children. Pediatr Infect Dis J (1995) 0.94
Hydroheptin: a water-soluble polyene macrolide. I. Taxonomy, fermentation and isolation. J Antibiot (Tokyo) (1979) 0.94
Lipophilic 1,1-bisphosphonates are potent squalene synthase inhibitors and orally active cholesterol lowering agents in vivo. J Biol Chem (1993) 0.93
Susceptibility of staphylococci to new antimicrobial agents. Antimicrob Agents Chemother (Bethesda) (1967) 0.93
Evidence for a role of the amino-terminal region in the biological activity of the classical anaphylatoxin, porcine C5a des-Arg-74. J Biol Chem (1985) 0.91
Amoxicillin therapy of acute urinary infections in adults. Antimicrob Agents Chemother (1977) 0.91
Providence bacillus bacteremia and septicopyemia. Am J Med (1968) 0.91
Comparative susceptibility of four kinds of pathogenic fungi to amphotericin B and amphotericin B methyl ester. Antimicrob Agents Chemother (1978) 0.91
Studies on the absorption, distribution and excretion of radioactivity after intravenous and intraperitoneal administration of 14C-methyl ester of amphotericin B. J Antibiot (Tokyo) (1975) 0.91